|
DENND4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.052600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.773400E-01 |
| Normal-vs-Stage2 |
3.347000E-01 |
| Normal-vs-Stage3 |
6.320600E-01 |
| Normal-vs-Stage4 |
7.099400E-01 |
| Stage1-vs-Stage2 |
1.448040E-01 |
| Stage1-vs-Stage3 |
3.299600E-01 |
| Stage1-vs-Stage4 |
9.035000E-01 |
| Stage2-vs-Stage3 |
6.549600E-01 |
| Stage2-vs-Stage4 |
3.586400E-01 |
| Stage3-vs-Stage4 |
5.407200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.054800E-01 |
| Normal-vs-AfricanAmerican |
9.044000E-01 |
| Normal-vs-Asian |
2.147400E-01 |
| Caucasian-vs-AfricanAmerican |
4.040200E-01 |
| Caucasian-vs-Asian |
2.167600E-01 |
| AfricanAmerican-vs-Asian |
3.375200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.505400E-01 |
| Normal-vs-Female |
1.442400E-01 |
| Male-vs-Female |
7.984100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.541200E-01 |
| Normal-vs-Extreme_Weight |
7.183400E-01 |
| Normal-vs-Obese |
4.229200E-01 |
| Normal-vs-Extreme_Obese |
9.685000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.710200E-01 |
| Normal_Weight-vs-Obese |
8.748200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.859800E-01 |
| Extreme_Weight-vs-Obese |
1.824750E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.729400E-01 |
| Obese-vs-Extreme_Obese |
4.768200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.734500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.779800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.697800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.469700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.089010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.285610E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.501540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.339600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.214170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.748600E-01 |
| Normal-VS-Type2 PRCC |
4.425200E-01 |
| Normal-VS-KIRP CIMP |
1.752630E-01 |
| Normal-VS-Unclassified PRCC |
5.467500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.721800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.158600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.306200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.674400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.704400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.422600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.367400E-01 |
| Normal-vs-N1 |
1.595790E-01 |
| Normal-vs-N2 |
2.399800E-01 |
| N0-vs-N1 |
7.322400E-02 |
| N0-vs-N2 |
1.767770E-01 |
| N1-vs-N2 |
9.472200E-01 |
|
|
